Moderate riskFDA DrugClass II

Blaine Labs vite20 antifungal cream recalled over stability testing lapse

Blaine Labs is recalling vite20 Antifungal Cream, lot BL3462, because the firm discontinued required stability testing for products still within their expiration date. The FDA classifies this as a Class II recall, and no injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check the bottle for lot BL3462 and expiration date 2/7/2027, with UPC 6 16728 00039 2.
  2. The notice doesn't say how to get a refund or replacement; contact Blaine Labs, Inc. or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, UPC 6 16728 00039 2.
UPC code
  • 616728000392
Sold in
Nationwide
Made for
All ages

This recall covers 8 products — see all of them.

Details

Units affected
26,475 bottles
Illnesses reported
None reported
Manufactured in
11037 Lockport Pl, N/A, Santa Fe Springs, CA, United States
Classification
Class II
Recall number
D-0696-2026

In the FDA's words

Description
vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, UPC 6 16728 00039 2. CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Lot BL3462, Exp. 2/7/2027 Distribution: Nationwide in the USA Affected quantity: 26,475 bottles
Hazard
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

8 products in this recall

Revitaderm, Terpenicol and more recalled for microbial contamination

Eight Blaine Labs and Trifluent Pharma wound care and antifungal products are recalled: Revitaderm, TRIDERGEL, TRIPENICOL S, TERPENICOL, vite20, Fungal Fusion and Revitaderm First Aid Antiseptic Gel. Samples of these non-sterile products showed Lysinibacillus fusiformis and other Bacillus species. The FDA has classified this as a Class I recall.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug